41
TITLE: Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases  Full Text
AUTHORS: Sheean, ME; Malikova, E; Duarte, D; Capovilla, G; Fregonese, L; Hofer, MP; Magrelli, A; Mariz, S; Mendez Hermida, F; Nistico, R; Leest, T; Sipsas, NV; Tsigkos, S; Vitezic, D; Larsson, K; Sepodes, B; Stoyanova Beninska, V;
PUBLISHED: 2020, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 25, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
42
TITLE: Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?
AUTHORS: Eichler, HG; Cavaleri, M; Enzmann, H; Scotti, F; Sepodes, B; Sweeney, F; Vamvakas, S; Rasi, G;
PUBLISHED: 2020, SOURCE: CLINICAL PHARMACOLOGY & THERAPEUTICS, VOLUME: 108, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
43
TITLE: Designation of orphan conditions in Europe: regulatory observations and considerations after implementation of regulation 141/2000
AUTHORS: Mariz, S; Westermark, K; Sepodes, B;
PUBLISHED: 2020, SOURCE: EXPERT OPINION ON ORPHAN DRUGS, VOLUME: 8, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
44
TITLE: The translational value of animal models in orphan medicines designations for rare paediatric neurological diseases  Full Text
AUTHORS: Duarte, DM; Lima, MBD; Sepodes, B;
PUBLISHED: 2020, SOURCE: REGULATORY TOXICOLOGY AND PHARMACOLOGY, VOLUME: 118
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
45
TITLE: Attenuation of Colonic Injury and Inflammation by Administration of a Phenolic Extract of Summer Savory (Satureja hortensis L.) in Experimental Inflammatory Bowel Disease in Mice
AUTHORS: Rocha, J; Leandro, R; Direito, R; Goncalves, M; Duarte, MP; Fernandes, A; Sepodes, B; Figueira, ME;
PUBLISHED: 2020, SOURCE: APPLIED SCIENCES-BASEL, VOLUME: 10, ISSUE: 23
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
46
TITLE: Optimising bench science to withstand regulatory scrutiny  Full Text
AUTHORS: Borg, JJ; Melchiorri, D; Sepodes, B; Caramella, CM; Tomino, C; Micallef, B; Serracino Inglott, A; Nistico, R;
PUBLISHED: 2019, SOURCE: PHARMACOLOGICAL RESEARCH, VOLUME: 139
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
47
TITLE: Hurdles in gene therapy regulatory approval: a retrospective analysis of European Marketing Authorization Applications  Full Text
AUTHORS: Carvalho, M; Martins, AP; Sepodes, B;
PUBLISHED: 2019, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 24, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 22
IN MY: ORCID
48
TITLE: Phytosomes with Persimmon (Diospyros kaki L.) Extract: Preparation and Preliminary Demonstration of In Vivo Tolerability  Full Text
AUTHORS: Direito, R; Reis, C ; Roque, L; Goncalves, M; Sanches Silva, A; Gaspar, MM ; Pinto, R; Rocha, J; Sepodes, B; Bronze, MR; Figueira, ME;
PUBLISHED: 2019, SOURCE: PHARMACEUTICS, VOLUME: 11, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 32
IN MY: ORCID
49
TITLE: Anti-inflammatory Effects of Persimmon (Diospyros kaki L.) in Experimental Rodent Rheumatoid Arthritis
AUTHORS: Direito, R; Rocha, J; Serra, AT; Fernandes, A; Freitas, M; Fernandes, E ; Pinto, R; Bronze, R; Sepodes, B; Figueira, ME;
PUBLISHED: 2019, SOURCE: Journal of Dietary Supplements
INDEXED IN: Scopus CrossRef: 2
IN MY: ORCID
50
TITLE: Reduction of inflammation and colon injury by a Pennyroyal phenolic extract in experimental inflammatory bowel disease in mice
AUTHORS: Rocha, J; Direito, R; Lima, A ; Mota, J; Goncalves, M; Duarte, MP; Solas, J; Peniche, BF; Fernandes, A; Pinto, R; Ferreira, RB ; Sepodes, B; Figueira, ME;
PUBLISHED: 2019, SOURCE: BIOMEDICINE & PHARMACOTHERAPY, VOLUME: 118
INDEXED IN: Scopus WOS CrossRef: 15 Handle
IN MY: ORCID
Page 5 of 14. Total results: 139.